Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Avidity Biosciences, Inc. (RNA) Preferred Shares Issued (2019 - 2020)

Avidity Biosciences' Preferred Shares Issued history spans 2 years, with the latest figure at $2.2 million for Q1 2020.

For Q1 2020, Preferred Shares Issued changed N/A year-over-year to $2.2 million; the TTM value through Dec 2020 reached $2.2 million, changed N/A, while the annual FY2020 figure was $2.2 million, 96.97% down from the prior year.
Preferred Shares Issued reached $2.2 million in Q1 2020 per RNA's latest filing, down from $72.6 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $72.6 million in Q4 2019 to a low of $2.2 million in Q1 2020.